Aavishkar Oral Strips

What Aavishkar Oral Strips does

Aavishkar Oral Strips is a Hyderabad, India-based B2B contract manufacturer of oral dissolving films (ODFs), founded in 2013 by Dinesh A.R. (CEO) and Anusha Sane (Managing Director). The company produces private-label oral thin films across pharmaceutical, nutraceutical, oral hygiene, ingestible beauty, and pet healthcare applications, serving 100+ clients in 25+ countries including the USA, Canada, Europe, and Japan. Its proprietary ThinSol® technology platform underpins the offering, backed by 4 granted patents and additional applications pending, with a formulation library spanning 170+ active ingredients, 100+ flavors, and 350+ SKUs across 10+ product categories.

The company operates a 220,000 sq ft manufacturing facility capable of producing 2 billion strips per year, with engineering headroom to scale to 9 billion strips annually. Its go-to-market is private-label and contract manufacturing for brand owners and pharmaceutical companies seeking oral thin film delivery as an alternative to traditional tablets, capsules, or liquids. The company has been profitable since 2018, remains debt-free, and has raised only a single angel round in 2015, indicating a capital-efficient, founder-controlled operating model rather than a venture-funded growth posture. In March 2026 it extended into the nicotine delivery vertical via a partnership with Rapid Dose Therapeutics, leveraging its patented film technology for regulated nicotine products.

Name

Aavishkar Oral Strips

Legal name

Aavishkar

Website

https://aavishkar.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

51–100 employees

Short description

Aavishkar Oral Strips is a Hyderabad-based B2B contract manufacturer of oral dissolving films using its proprietary ThinSol® technology, serving 100+ clients across 25+ countries in pharmaceutical, nutraceutical, oral hygiene, beauty, and pet healthcare categories.

Ownership category

akta.pro rank

Product category

Pharmaceutical and Nutraceutical Contract Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Dental Equipment and Supplies Manufacturing (339114), Nonchocolate Confectionery Manufacturing (31134)

SIC

Dental Equipment & Supplies (3843), Medicinal Chemicals & Botanical Products (2833), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Oral Care Products (Toothpaste, Mouthwash, Dental Floss, Whitening) (CRADAMAA)

akta.pro secondary industries

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Unit-Dose & Compliance Packaging (Sachets, Strip Packs, Pill Organizers) (IMALAIAH)

Keywords

• Oral dissolving films
• Private label manufacturing
• Nutraceutical contract manufacturing
• Oral thin film technology
• Pharmaceutical contract manufacturing

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Technology or R&D, Personnel, Infrastructure, Marketing or Sales

Revenue model

1. Private Label Manufacturing: Aavishkar manufactures oral dissolving films as a private label/contract manufacturer for brands. They provide end-to-end solutions from formulation to secondary packing, serving as a 360° partner from ideation to retail delivery. Revenue is generated through manufacturing fees and formulation development services.
2. Custom Formulation Development: Provides customisation from scratch including development of new formulas based on client ideas. Active ingredient combinations, flavour options, shapes and sizes are offered. Revenue generated through R&D and development fees alongside manufacturing.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Aavishkar Oral Strips is a global B2B private label manufacturer of oral dissolving films (ODFs) built around its proprietary ThinSol® technology. The company provides end-to-end 360° solutions—from ideation, custom formulation development, and R&D through manufacturing, packaging, and retail-ready delivery—for nutraceutical, pharmaceutical, oral hygiene, ingestible beauty, and pet healthcare brands. Its 220,000 sq. ft. cGMP-certified facility in Hyderabad can produce 2 billion strips annually (scalable to 9 billion), with a portfolio of 350+ SKUs, 100+ flavors, and 170+ active ingredients across 10+ categories.

Product overview

Aavishkar is a global private label manufacturer of oral dissolving films (ODFs) using its proprietary ThinSol® technology. The company operates a single unified product platform built around ThinSol® — a patented oral thin film technology that enables rapid dissolution, taste masking through microencapsulation, and delivery of various active ingredients (vitamins, minerals, herbals, probiotics) with minimal excipients. The product portfolio spans multiple categories including nutraceutical supplements, oral hygiene products, ingestible beauty, and pet healthcare, comprising 350+ SKUs across 10 categories in 100+ flavors. Aavishkar functions as a B2B private label manufacturer, providing formulation development, manufacturing, and packaging services to brand partners, rather than selling consumer products directly.

Differentiator

Problem solved

Functional benefit

Brands

• ThinSol®: Proprietary oral dissolving strip technology enabling microencapsulation, patented low temperature drying, improved stability and shelf life, customized combinations and dosages for nutraceutical and pharmaceutical applications.

Products and services

• Nutraceutical Oral Strips
• Oral Hygiene Oral Strips
• Ingestible Beauty Oral Strips
• Pet Healthcare Oral Strips
• Natural Cough Strips (Expectorant)
• Encapsulated Iron Oral Strips
• Nanotized Herbal Oral Strips
• Probiotic Oral Thin Film

Quantifiable outcome

• Dissolves in under 30 seconds
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Rapid Dose Therapeutics Corp. (DOSE/RDTCF)coreTechnology or Integration · 5 March 2026Strategic patent partnership for QuickStrip™ Nicotine Bilayer Oral Film technology. Aavishkar partnered with the Canadian biotech company Rapid Dose Therapeutics to secure patent protection (Patent No. IN 582202) from the Indian Patent Office for controlled nicotine delivery technology. The partnership extends potential patent protection to up to 158 jurisdictions via WIPO PCT filing and strengthens negotiating position with a major global nicotine company they have been engaged with for nearly three years.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Cure Pharmaceutical (CURE): Cure Pharmaceutical develops and manufactures oral thin film dosage forms using its CureFilm® technology. Comparable to Aavishkar through private-label oral dissolving film capabilities targeting both nutraceutical and pharmaceutical end markets.
• IntelGenx Technologies Corp. IntelGenx develops and manufactures oral thin film pharmaceutical products using its VersaFilm® technology platform, serving brand partners via CDMO agreements. Direct peer in business model and oral thin film focus, with comparable nutraceutical and pharma applications.
• Aquestive Therapeutics: Aquestive (formerly MonoSol Rx) develops and manufactures oral film-based pharmaceutical products with proprietary PharmFilm® technology. Comparable to Aavishkar in using a proprietary oral film platform across multiple therapeutic categories and offering both captive products and partner programs.
• LTS Lohmann Therapie-Systeme: LTS is a German-founded CDMO specializing in oral thin film and transdermal patch manufacturing for pharma and consumer health. It is the most direct comparability for Aavishkar's private-label oral dissolving film manufacturing model, including global multi-category capability.
• BioDelivery Sciences International (Collegium Pharmaceutical): BioDelivery Sciences pioneered oral film pharmaceutical products (e.g., buprenorphine/naloxone sublingual film) and was acquired by Collegium. Comparable to Aavishkar in deploying proprietary oral thin film delivery technology for therapeutic applications.
• ARx Pharmaceuticals: ARx is a private oral thin film CDMO specializing in formulation development and GMP manufacturing of dissolvable oral strips. Direct peer in business model (B2B oral film manufacturing) and customer type (brand partners seeking differentiated dosage forms).

Broad incumbents

• Kyowa Kirin: Kyowa Kirin is a global specialty pharmaceutical company with proprietary oral film-based products (e.g., fentanyl citrate sublingual film). Comparable as a broad incumbent using oral dissolving films as part of a wider specialty pharma portfolio, though not a CDMO competitor.

Emerging players

• Rapid Dose Therapeutics Corp. Rapid Dose Therapeutics is a Canadian biotech that partners with Aavishkar on QuickStrip™ nicotine bilayer oral film and holds Indian Patent No. IN 582202 jointly. Relevant as a complementary emerging player in the same oral dissolving film space, focused on drug delivery applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/AavishkarOral
• Facebookfacebook.com/bharathaavishkar003
• LinkedInlinkedin.com/company/aavishkar-oral-strips

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aavishkar Oral Strips